Staphylococcus aureus FDA 209P cells when suspended in 24% (w/v) NaCl were rendered osmotically fragile by exposure to lysostaphin for time intervals ranging from 2 to 60 min. Such cells were analyzed chemically and serologically for evidence of residual cell wall material, were plated in hypertonic sucrose medium to determine revertibility to normal, and were subjected to manometric studies to determine metabolic capabilities. Most of the cells (95%) which were exposed to lysostaphin (0.5 or 1.0 unit/ml) for 2 min, although osmotically fragile, retained their cell wall hexosamine and were capable of reverting to osmotically normal cells when plated in hypertonic medium. Cells exposed to lysostaphin for 5 and 10 min also retained much of their cell wall hexosamine, but lost their ability to revert to normal staphylococci. Cells exposed to lysostaphin for 2 to 10 min continued to react with staphylococcus anti-k antiserum. Complete removal of cell wall hexosamine was attained only after exposure to lysostaphin for 20 min or more; these cells failed to react with k antiserum. Lysostaphin-induced L-type colonies were extremely rare in our experiments, even if incubation times and media were optimal for their detection. Lysostaphin-induced staphylococcal protoplasts were as active metabolically in manometric studies as were untreated staphylococci.
The formation of osmotically fragile Staphylococcus aureus cells due to exposure to lysostaphin (7, 8) was described by Schuhardt and Klesius (10) and by Schuhardt, Huber, and Pope (9) . Further observations on the biochemical, serological, and physiological properties of these osmotically fragile S. aureus cells are presented in this paper.
MATERIALS AND METHODS
Organism and culture media. S. aureus FDA 209P (9) was grown in Brain Heart Infusion (BHI; Difco) for 18 hr at 37 C with shake aeration. Hypertonic, semisolid BHI Agar for osmotically protected overlay plating of the fragile cells was prepared as previously described (10) . S. aureus L-form 160 was obtained from J. H. Marston, Baylor University College of Medicine, Houston, Tex., and was grown in BHI containing 5% NaCl with or without 5% inactivated horse serum.
Lysostaphin treatment of cells and viability studies. Solutions of lysostaphin, buffered 30% (w/v) NaCl, and 0.05 M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride buffer were prepared as previously described (9) . Approximately 109 cells/ml were exposed to lysostaphin in buffered hypertonic NaCl for timed intervals. Treated cell suspensions were assayed for revertible viability and for osmotic sensitivity by comparing the colony counts of osmotically protected and osmotically shocked preparations as described (9) . In these, as in prior studies, a number of revertant spheroplasts colonies from the osmotically protected platings were transferred to BHI broth and agar to test for osmotic stability and for parental strain characteristics of the reverted cells.
Cell wall extraction, hydrolysis, and hexosamine determination. Approximately 1.3 mg (dry weight) of cells was extracted for peptidoglycans by the hot trichloroacetic acid method of Park and Hancock (6) . The peptidoglycan preparations were hydrolyzed in sealed ampoules with 4 N HCl at 100 C for 4 hr. The hydrolysates of the peptidoglycans were evaporated to dryness, dissolved in 1 ml of deionized water, and analyzed for hexosamine by the method of Belcher, Nutten, and Sambrook (1).
Serological typing. Cells treated with lysostaphin, cells from colonies of revwrted spheroplasts, and untreated control cells were fixed in 4% Formalin (10) , washed in Tris buffer, and serotyped by the procedure of Cohen and Smith (2) .
Metabolic activity of protoplasts. Protoplasts were formed by exposing S. aureus cells (3 X 1010/ml) in buffered 24% NaCl to 50 ,g of lysostaphin per ml for 1 hr at 37 C. Controls consisted of (i) 3 X 1010 cells/ ml in buffered 24% NaCl and (ii) 3 X 1010 cells/ml lysed by exposure to lysostaphin in Tris buffer after which NaCI was added to a 24% concentration. The Table 1 . There was no significant difference in the yields of viable (revertible) and nonviable cells from preparations treated with lysostaphin concentrations of 1 and 0.5 units/ml. However, the preparation exposed to 0.2 units of lysostaphin per ml showed a significant decrease in the rate of formation of osmotically fragile spheroplasts. Here, the maximal yield (83%) was reached after 5 min of exposure to lysostaphin as contrasted to the maximal yields at 2 min with the higher concentrations. The percentage of spheroplasts in these samples was calculated with respect to the colony counts of the preparations treated for 2 min and the osmotically protected preparations rather than the untreated control counts. This was done because the former counts frequently were higher than the latter, owing to the early clump-dispersing properties of the lysostaphin (9 Lysostaphin removal of cell wall hexosamine. Figure 1 depicts the effect of exposure to lysostaphin on the cell wall hexosamine content. About half the hexosamine present in untreated cells was still detectable on the osmotically fragile cells after 10 min of exposure to lysostaphin. Digestion of the cell wall into soluble fragments (not sedimentable at 4,000 X g) was essentially complete at 60 min.
Metabolic activity of protoplasts. The metabolic activities of protoplasts, whole cells, and cell lysates in 24% NaCI is illustrated in Fig. 2 lysates failed to take up oxygen at a measurabl rate. Protoplasts respired as well as, if not bette than, whole cells in the presence of glucose. N( cell wall hexosamine was detectable chemically i] these protoplast preparations. Lysostaphin treatment of L-forms. S. aureu L-forms, which possessed less than 0.3 ,ug of cel wall hexosamine per 101' cells, were exposed t( lysostaphin (1 unit/ml) to determine whether th enzyme might contain ingredients deleterious to , cell component other than the cell wall. Botl turbidity measurements and colony plating indi cated no significant effect of lysostaphin treatmen on the staphylococcus L-forms. Lysostaphin treated and untreated S. aureus L-forms wer stable in 5% NaCl but rapidly lost turbidity an( viability when suspended in hypotonic solutions DISCUSSION In a prior paper (9), we described three types o lysostaphin-induced, osmotically fragile staphylo cocci: spheroplasts which could revert to os motically normal cells, protoplast-like bodie which could not revert but retained cell wall, an( protoplasts which neither possessed cell wall no were revertible. L-forms constitute still anothe class of osmotically fragile staphylococcal cells These were rarely detected in our osmoti fragility experiments. Efforts to determine th frequency of lysostaphin-induced L-forms of S aureus FDA 209P indicated that L-forms aros( from these staphylococcal cells at a frequency of only 10ff to 10-v. Our results are consistent with those of Dienes (3) , who used other L-form inducing agents. However, they are lower than the maximal yields of staphylococcal L-colonies (0.002%) reported by Watanokunokorn et al. (11) , who used graded doses of lysostaphin ranging from 1 to 600 mg/ml incorporated in the agar medium. These workers reported no Lcolonies in preparations from both extreme concentrations of the enzyme.
The results of serological analysis for surface antigens and chemical analysis for cell wall hexosamine were consistent with our electron microscopic detection of cell walls (9) . Chemical analysis detected more cell wall material in treated cells than did electron microscopic and serological analyses, because cell-free fragments of cell walls were more likely to be detectable by the chemical test.
The fact that S. aureus cells which were treated with lysostaphin for 5 or 10 min retained much of S their cell wall as indicated microscopically (9) and chemically, but were unable to revert to osmotic normalcy, indicates that this residual staphylococcal cell wall was not capable of e functioning as the "indispensable primer" ( 
